These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15037160)

  • 1. Determinants of F2-isoprostane biosynthesis and inhibition in man.
    Davì G; Falco A; Patrono C
    Chem Phys Lipids; 2004 Mar; 128(1-2):149-63. PubMed ID: 15037160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprostane formation and inhibition in atherothrombosis.
    Patrono C; Falco A; Davì G
    Curr Opin Pharmacol; 2005 Apr; 5(2):198-203. PubMed ID: 15780831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidant stress, inflammation and atherogenesis.
    Davì G; Falco A
    Lupus; 2005; 14(9):760-4. PubMed ID: 16218483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprostanes and other markers of peroxidation in atherosclerosis.
    Patrignani P; Tacconelli S
    Biomarkers; 2005 Nov; 10 Suppl 1():S24-9. PubMed ID: 16298908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
    Praticò D; Rokach J; Lawson J; FitzGerald GA
    Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in chronic renal failure as a cardiovascular risk factor.
    Siems W; Quast S; Carluccio F; Wiswedel I; Hirsch D; Augustin W; Hampi H; Riehle M; Sommerburg O
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S12-9. PubMed ID: 12227720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B; Nofer TW; Wasowicz W
    Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men.
    Helmersson J; Arnlöv J; Vessby B; Larsson A; Alfthan G; Basu S
    Free Radic Res; 2005 Jul; 39(7):763-70. PubMed ID: 16036356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidant stress modulates murine allergic airway responses.
    Talati M; Meyrick B; Peebles RS; Davies SS; Dworski R; Mernaugh R; Mitchell D; Boothby M; Roberts LJ; Sheller JR
    Free Radic Biol Med; 2006 Apr; 40(7):1210-9. PubMed ID: 16545689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders.
    Cracowski JL; Marpeau C; Carpentier PH; Imbert B; Hunt M; Stanke-Labesque F; Bessard G
    Arthritis Rheum; 2001 May; 44(5):1143-8. PubMed ID: 11352247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E modulation of cardiovascular disease.
    Meydani M
    Ann N Y Acad Sci; 2004 Dec; 1031():271-9. PubMed ID: 15753153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.
    Roberts LJ; Fessel JP
    Chem Phys Lipids; 2004 Mar; 128(1-2):173-86. PubMed ID: 15037162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo markers of oxidative stress and therapeutic interventions.
    Tsimikas S
    Am J Cardiol; 2008 May; 101(10A):34D-42D. PubMed ID: 18474272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women.
    Hartman TJ; Baer DJ; Graham LB; Stone WL; Gunter EW; Parker CE; Albert PS; Dorgan JF; Clevidence BA; Campbell WS; Tomer KB; Judd JT; Taylor PR
    Eur J Clin Nutr; 2005 Feb; 59(2):161-8. PubMed ID: 15367922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and oxidative stress in arterial hypertension.
    Ferroni P; Basili S; Paoletti V; Davì G
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):222-33. PubMed ID: 16580590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.